Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Taro Pharm Inds (TARO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 03/31

(Values in U.S. thousands)

	03-2020	12-2019	09-2019	06-2019	03-2019
Assets
Current Assets
Cash & Cash Equivalents	513,354	509,361	560,667	632,986	567,451
Marketable Securities	595,383	542,032	496,948	506,751	481,883
Receivables	270,788	248,442	273,812	245,635	285,307
Inventories	153,073	157,875	148,439	148,283	148,079
TOTAL	$1,532,598	$1,457,710	$1,479,866	$1,533,655	$1,482,720

Non-Current Assets
PPE Net	209,961	206,692	206,727	205,654	206,242
Investments And Advances	459,639	479,050	417,778	291,544	304,322
Other Non-Current Assets	139,054	147,511	145,335	141,347	142,042
TOTAL	$808,654	$833,253	$769,840	$638,545	$652,606

Total Assets	$2,341,252	$2,290,963	$2,249,706	$2,172,200	$2,135,326

Liabilities
Current Liabilities
Accounts payable and accrued liabilities	28,858	37,035	38,409	37,210	35,060
Other current liabilities	193,873	177,144	171,092	152,023	181,761
TOTAL	$222,731	$214,179	$209,501	$189,233	$216,821

Non-Current Liabilities
Other Non-Current Liabilities	5,142	6	-32	-58	4,356
TOTAL	$8,762	$8,180	$8,899	$8,122	$7,383

Total Liabilities	$231,493	$222,359	$218,400	$197,355	$224,204

Shareholders' Equity
Common Shares	679	N/A	N/A	N/A	679
Retained earnings	2,725,270	N/A	N/A	N/A	2,481,029
Other shareholders' equity	-157,635	2,068,604	2,031,306	1,974,845	-138,031
TOTAL	$2,109,759	$2,068,604	$2,031,306	$1,974,845	$1,911,122

Total Liabilities And Equity	$2,341,252	$2,290,963	$2,249,706	$2,172,200	$2,135,326